Fareed J - Search Results

1

Successful Coronary Interventions Performed with Argatroban Anticoagulation in Patients with Heparin-Induced Thrombocytopenia and Thrombosis Syndrome.

Lewis BE, Ferguson JJ, Grassman ED, Fareed J, Walenga J, Joffrion JL, Wrona L, Johnson SA, Schwarz RP Jr, McKiernan T. Lewis BE, et al. Among authors: fareed j. J Invasive Cardiol. 1996 Nov;8(9):410-417. J Invasive Cardiol. 1996. PMID: 10785742

2

Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.

Chamberlin JR, Lewis B, Leya F, Wallis D, Messmore H, Hoppensteadt D, Walenga JM, Moran S, Fareed J, McKiernan T. Chamberlin JR, et al. Among authors: fareed j. Can J Cardiol. 1995 Jun;11(6):511-4. Can J Cardiol. 1995. PMID: 7780873

3

A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty.

Grassman ED, Leya F, Fareed J, Lewis BE, Bacher P, Loeb HS, Moran JF. Grassman ED, et al. Among authors: fareed j. J Invasive Cardiol. 2001 Nov;13(11):723-8. J Invasive Cardiol. 2001. PMID: 11689712 Clinical Trial.

4

Current status on new anticoagulant and antithrombotic drugs and devices.

Walenga JM, Fareed J. Walenga JM, et al. Among authors: fareed j. Curr Opin Pulm Med. 1997 Jul;3(4):291-302. doi: 10.1097/00063198-199707000-00010. Curr Opin Pulm Med. 1997. PMID: 9262116 Review.

5

Simultaneous monitoring of argatroban and its major metabolite using an HPLC method: potential clinical applications.

Ahmad S, Ahsan A, George M, Iqbal O, Jeske WP, McKenna R, Lewis BE, Walenga JM, Fareed J. Ahmad S, et al. Among authors: fareed j. Clin Appl Thromb Hemost. 1999 Oct;5(4):252-8. doi: 10.1177/107602969900500409. Clin Appl Thromb Hemost. 1999. PMID: 10726023 Free article.

6

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ, Kelton JG; ARG-911 Study Investigators. Lewis BE, et al. Among authors: fareed j. Circulation. 2001 Apr 10;103(14):1838-43. doi: 10.1161/01.cir.103.14.1838. Circulation. 2001. PMID: 11294800 Clinical Trial.

7

Pharmacology of argatroban.

Jeske W, Walenga JM, Lewis BE, Fareed J. Jeske W, et al. Among authors: fareed j. Expert Opin Investig Drugs. 1999 May;8(5):625-54. doi: 10.1517/13543784.8.5.625. Expert Opin Investig Drugs. 1999. PMID: 15992120

8

Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspective.

Walenga JM, Hoppensteadt D, Fareed J. Walenga JM, et al. Among authors: fareed j. Semin Thromb Hemost. 1991;17 Suppl 2:137-42. Semin Thromb Hemost. 1991. PMID: 1835134 Review.

9

Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.

Hoppensteadt DA, Walenga JM, Fareed J. Hoppensteadt DA, et al. Among authors: fareed j. Semin Thromb Hemost. 1991;17 Suppl 1:60-4. Semin Thromb Hemost. 1991. PMID: 2068572

10

Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparin.

Hoppensteadt D, Walenga JM, Fareed J. Hoppensteadt D, et al. Among authors: fareed j. Thromb Res. 1990 Nov 1;60(3):191-200. doi: 10.1016/0049-3848(90)90180-k. Thromb Res. 1990. PMID: 2084948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

768 results

Search Page